Skip to content
Terminus Peptides
  • Research use only — not for human or veterinary use
  • 55 compound profiles, every source cited
  • 62 research materials listed
  • Prices published, not hidden behind an enquiry
  • Vials and pre-filled pens
  • Dispatched and supported from the UK
  • Every profile states its UK regulatory status

Research profile · Research reagent

Acetic acid solution

Also known as E260, Glacial acetic acid (concentrate)

Not assessed — evidence level 0 of 4: Evidence not yet assessedNot a medicine — UK regulatory status: Not classified as a medicinal product

Overview

A dilute acid used to adjust pH. A food additive and a pharmaceutical excipient, not a medicine in its own right.

Category
Research reagent
Highest evidence level identified
Evidence not yet assessed
Last scientifically reviewed
20 August 2026
Last regulatory review
20 August 2026

Mechanism under investigation

Acetic acid is a short-chain carboxylic acid used in dilute aqueous solution to lower pH. In pharmaceutical formulation it functions as a pH-adjusting excipient; applied to a body surface, its acidification is antimicrobial. It has no systemic therapeutic action at the concentrations used as a formulation component, and it is a routine constituent of the diet.

Research areas

  • Laboratory preparation

These are fields in which the compound has been investigated. Listing a field is not a statement that anything was demonstrated within it.

Current evidence

In-vitro evidence

Cells, tissues or biochemical systems outside a living organism.

No published in-vitro study of dilute acetic acid as a peptide diluent was located. Recorded as absent rather than filled with adjacent material.

Animal evidence

Studies in living non-human animals.

Absent for this use.

Human observational evidence

Studies observing people without assigning an intervention.

Absent for this use.

Clinical-trial evidence

Studies assigning an intervention to human participants.

None for use as a diluent. Clinical evidence exists only for a different product at a different strength by a different route — a 2 per cent topical spray for the outer ear, which is a pharmacy medicine in the UK.

Study limitations

  • This substance is listed because it is used in laboratory preparation, not because it is an intervention. For that use there is no evidence at any tier, and the absence is genuine rather than a gap in searching — no such evidence has ever been generated, because it is a formulation component.
  • The licensed UK evidence relates to a different concentration, a different route and a different purpose. It does not transfer.
  • Food-additive authorisation governs dietary exposure by mouth. It says nothing about sterility, endotoxin limits or particulate standards.
  • A dilute acetic acid solution presented with claims about preparing injectable medicines would be assessed under the medicines regime. The classification below describes the substance, not every way it might be marketed.

UK regulatory context

Not classified as a medicinal product

A substance that, in the described context, is not regulated as a medicinal product in the UK. Classification can depend on presentation and claimed purpose.

Source: Regulated products register: acetic acid (E 260) (opens data.food.gov.uk in a new tab) (Food Standards Agency)

Regulatory classification is jurisdiction-specific. A compound authorised elsewhere is not thereby authorised in the UK, and a supplier’s description of a substance does not determine how it is classified in law. See safety and regulation for the framework and the authoritative sources.

Safety and interpretation

As an excipient at pH-adjusting quantities and as a food acidulant, acetic acid is of very low toxicological concern. The meaningful risks attach to context rather than to the molecule: a solution supplied outside the medicines framework carries no assured sterility, endotoxin limit or concentration accuracy. Concentrated acetic acid is corrosive to skin, eyes and mucous membranes. The warnings attached to the licensed topical ear product concern local stinging and duration of use, and do not extrapolate to any other route.

References